hiPSC-Based Tissue Organoid Regeneration

[1]  Hideyuki Okano,et al.  iPS cell technologies: significance and applications to CNS regeneration and disease , 2014, Molecular Brain.

[2]  T. Karlsen,et al.  Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.

[3]  H. Niemann,et al.  The small molecule inhibitors PD0325091 and CHIR99021 reduce expression of pluripotency-related genes in putative porcine induced pluripotent stem cells. , 2014, Cellular reprogramming.

[4]  Kumaraswamy Nanthakumar,et al.  Biowire: a New Platform for Maturation of Human Pluripotent Stem Cell Derived Cardiomyocytes Pubmed Central Canada , 2022 .

[5]  Luca Biasco,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome , 2013, Science.

[6]  Gail H Deutsch,et al.  In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.

[7]  J. Cashman,et al.  Small-Molecule Inhibitors of the Wnt Pathway Potently Promote Cardiomyocytes From Human Embryonic Stem Cell–Derived Mesoderm , 2011, Circulation research.

[8]  D. Zink,et al.  Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications. , 2017, Biotechnology advances.

[9]  Sean P. Palecek,et al.  Chemically defined, albumin-free human cardiomyocyte generation , 2015, Nature Methods.

[10]  Irena Melnikova,et al.  Rare diseases and orphan drugs , 2012, Nature Reviews Drug Discovery.

[11]  L. Leinwand,et al.  Cellular mechanisms of cardiomyopathy , 2011, The Journal of cell biology.

[12]  K. Sasaki,et al.  Reprogramming of retinoblastoma cancer cells into cancer stem cells. , 2017, Biochemical and biophysical research communications.

[13]  A. Bradley,et al.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells , 2011, Nature.

[14]  Ronald A. Li,et al.  Calcium signalling of human pluripotent stem cell‐derived cardiomyocytes , 2013, The Journal of physiology.

[15]  Michael Schumacher,et al.  Modeling human development and disease in pluripotent stem cell-derived gastric organoids , 2014, Nature.

[16]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[17]  R. Drapkin,et al.  Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms , 2013, Front. Oncol..

[18]  H. Snoeck,et al.  Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. , 2012, Cell stem cell.

[19]  A. Hyman,et al.  CPAP promotes timely cilium disassembly to maintain neural progenitor pool , 2016, The EMBO journal.

[20]  Laura M. Palermo,et al.  A three-dimensional model of human lung development and disease from pluripotent stem cells , 2017, Nature Cell Biology.

[21]  Elizabeth E. Hoskins,et al.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro , 2010, Nature.

[22]  H. Sugiyama,et al.  Identification of a small molecule that turns ON the pluripotency gene circuitry in human fibroblasts. , 2014, ACS chemical biology.

[23]  Beatrice A. Howard,et al.  Prenatal Morphogenesis of Mammary Glands in Mouse and Rabbit , 2013, Journal of Mammary Gland Biology and Neoplasia.

[24]  Jonathan M. Brunger,et al.  Genome Engineering for Personalized Arthritis Therapeutics. , 2017, Trends in molecular medicine.

[25]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[26]  N. Zavazava,et al.  Strategies to generate induced pluripotent stem cells. , 2013, Methods in molecular biology.

[27]  S. Lienkamp,et al.  Engineering kidney cells: reprogramming and directed differentiation to renal tissues , 2017, Cell and Tissue Research.

[28]  T. Shiina,et al.  Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates , 2016, Stem cell reports.

[29]  Arnold R. Kriegstein,et al.  The use of brain organoids to investigate neural development and disease , 2017, Nature Reviews Neuroscience.

[30]  Zongyou Guo,et al.  Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa , 2016, Proceedings of the National Academy of Sciences.

[31]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[32]  A. Christiano,et al.  Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells , 2011, Proceedings of the National Academy of Sciences.

[33]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[34]  G. Göhring,et al.  Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions. , 2017, Stem cell research.

[35]  Teruo Fujii,et al.  Organ/body-on-a-chip based on microfluidic technology for drug discovery. , 2017, Drug metabolism and pharmacokinetics.

[36]  A. Robin,et al.  Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma , 2014, Journal of stem cell research & therapy.

[37]  Nazish Sayed,et al.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. , 2016, Journal of the American College of Cardiology.

[38]  U. Martin.  Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks , 2017, Front. Med..

[39]  Laura E Niklason,et al.  Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. , 2014, Biomaterials.

[40]  Shinya Yamanaka,et al.  Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression , 2011, PloS one.

[41]  M. Gerstein,et al.  FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.

[42]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[43]  M. Mikkola,et al.  Genetic basis of skin appendage development. , 2007, Seminars in cell & developmental biology.

[44]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[45]  E. Wolvetang,et al.  Primitive cardiac cells from human embryonic stem cells. , 2012, Stem cells and development.

[46]  E. Stanley,et al.  Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney , 2013, Nature Cell Biology.

[47]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[48]  R. Kurman.  Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  Noah F. Shroyer,et al.  Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling. , 2017, Cell stem cell.

[50]  Carolyn M. Scott,et al.  Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium , 2016, Stem cells translational medicine.

[51]  Teruo Fujii,et al.  Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons , 2017, Stem cell reports.

[52]  Angela M. Christiano,et al.  Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells (iPSCs) , 2013, PloS one.

[53]  G. Vunjak‐Novakovic,et al.  Highly efficient generation of airway and lung epithelial cells from human pluripotent stem cells , 2013, Nature Biotechnology.

[54]  J. D. Macklis,et al.  Modeling ALS with motor neurons derived from human induced pluripotent stem cells , 2016, Nature Neuroscience.

[55]  Tara Srinivasan,et al.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing , 2017, Nature Medicine.

[56]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[57]  Jing Zhou,et al.  Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids , 2015, Nature Communications.

[58]  David W. Nauen,et al.  Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.

[59]  Benjamin S. Freedman,et al.  Nephron organoids derived from human pluripotent stem cells model kidney development and injury , 2015, Nature Biotechnology.

[60]  M. Tomizawa,et al.  Transcription Factors and Medium Suitable for Initiating the Differentiation of Human‐Induced Pluripotent Stem Cells to the Hepatocyte Lineage , 2016, Journal of cellular biochemistry.

[61]  Da-Woon Jung,et al.  Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. , 2014, ACS chemical biology.

[62]  S. Quaggin,et al.  Signaling during Kidney Development , 2015, Cells.

[63]  Hans Clevers,et al.  Organoid culture systems for prostate epithelial tissue and prostate cancer tissue , 2016, Nature Protocols.

[64]  Laura E Niklason,et al.  Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. , 2013, Journal of Clinical Investigation.

[65]  H. Kiyono,et al.  A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids , 2017, Stem cell reports.

[66]  Shinya Yamanaka,et al.  Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.

[67]  F. Cugola,et al.  Induced pluripotent stem cells for modeling neurological disorders. , 2015, World journal of transplantation.

[68]  He Zhang,et al.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.

[69]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[70]  F. Gage,et al.  Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells , 2014, Proceedings of the National Academy of Sciences.

[71]  M. Noseda,et al.  Cardiopoietic factors: extracellular signals for cardiac lineage commitment. , 2011, Circulation research.

[72]  Mathias J Friedrich,et al.  CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice , 2015, Proceedings of the National Academy of Sciences.

[73]  H. Okano,et al.  Generation of Human Melanocytes from Induced Pluripotent Stem Cells , 2011, PloS one.

[74]  P. Garcez,et al.  Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.

[75]  Joseph C. Wu,et al.  Patient-specific stem cells and cardiovascular drug discovery. , 2013, JAMA.

[76]  S. Erceg,et al.  Generation of a human iPSC line by mRNA reprogramming. , 2018, Stem cell research.

[77]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[78]  Julia Gorelik,et al.  Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy? , 2011, Journal of molecular and cellular cardiology.

[79]  Ali Khademhosseini,et al.  Biomimetic tissues on a chip for drug discovery. , 2012, Drug discovery today.

[80]  Deok‐Ho Kim,et al.  Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. , 2017, Biotechnology advances.

[81]  T. Evans,et al.  Modeling Cystic Fibrosis Using Pluripotent Stem Cell‐Derived Human Pancreatic Ductal Epithelial Cells , 2016, Stem cells translational medicine.

[82]  Sukhdeep Singh,et al.  The future of the patient-specific Body-on-a-chip. , 2013, Lab on a chip.

[83]  S. Lopes,et al.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.

[84]  F. Choy,et al.  A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells , 2017, Diseases.

[85]  Gordon Keller,et al.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.

[86]  A. Giuliano,et al.  Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids , 2017, Stem cell reports.

[87]  E. White,et al.  Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids , 2015, Biology Open.

[88]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[89]  Alyssa J. Miller,et al.  A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids , 2016, eLife.

[90]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[91]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[92]  D. Geschwind,et al.  Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.

[93]  Azra Fatima,et al.  In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.

[94]  D. Papatsenko,et al.  Modeling Familial Cancer with Induced Pluripotent Stem Cells , 2015, Cell.

[95]  Xi Ren,et al.  Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. , 2014, The Annals of thoracic surgery.

[96]  Gordon Keller,et al.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. , 2011, Cell stem cell.

[97]  M. Eiraku,et al.  Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell–derived neocortex , 2013, Proceedings of the National Academy of Sciences.

[98]  M. Mahfouz,et al.  Genome editing: the road of CRISPR/Cas9 from bench to clinic , 2016, Experimental & Molecular Medicine.

[99]  K. Jimbow,et al.  Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells. , 2018, The Journal of investigative dermatology.

[100]  Richard L. Frock,et al.  Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases , 2014, Nature Biotechnology.

[101]  C. Robson,et al.  Using induced pluripotent stem cells as a tool for modelling carcinogenesis. , 2015, World journal of stem cells.

[102]  Lil Pabon,et al.  Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes , 2014, Circulation research.

[103]  David V. Schaffer,et al.  Engineering adeno-associated viruses for clinical gene therapy , 2014, Nature Reviews Genetics.

[104]  G. Church,et al.  Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies , 2016, Nature Protocols.

[105]  K. Chien,et al.  How to make a cardiomyocyte , 2014, Development.

[106]  Jing Zhang,et al.  Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.

[107]  L. Ellerby,et al.  iPSC-based drug screening for Huntington׳s disease , 2016, Brain Research.

[108]  N. Katsanis,et al.  Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood , 2015, Stem Cell Reviews and Reports.

[109]  Paul W. Burridge,et al.  Human Stem Cells for Modeling Heart Disease and for Drug Discovery , 2014, Science Translational Medicine.

[110]  B. Karlan,et al.  Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium , 2017, Scientific Reports.

[111]  Donald M Bers,et al.  Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.

[112]  B. Cui,et al.  Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes , 2014, Nature methods.

[113]  W. Suh.  A new era of disease modeling and drug discovery using induced pluripotent stem cells , 2016, Archives of Pharmacal Research.

[114]  Adrian Ranga,et al.  Neural tube morphogenesis in synthetic 3D microenvironments , 2016, Proceedings of the National Academy of Sciences.

[115]  C. Svendsen,et al.  Human neural progenitor cells generated from induced pluripotent stem cells can survive, migrate, and integrate in the rodent spinal cord , 2014 .

[116]  R. Passier,et al.  NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.

[117]  E. Morrisey,et al.  Directing lung endoderm differentiation in pluripotent stem cells. , 2012, Cell stem cell.

[118]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[119]  J. Mayerle,et al.  Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling , 2016, Gut.